Health3 years ago
Despite the controversy, the DENT Neurologic Institute is preparing to proceed with the treatment of Alzheimer’s disease.
Buffalo, NY (WKBW) — The DENT Neurologic Institute is ready to proceed with the newly approved aducanumab (also known as aducanumab) for Alzheimer’s disease. Questions about...
Recent Comments